Cross-talk between pRb/E2F and Wnt/β-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death

Experimental Cell Research

Volumn 303, Issue 1, 2005, Pages 32-46

  Hughes, Thomas A ^a   Brady, Hugh J M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Axin2; Cell death; E2F1; Wnt

Indexed keywords

AXIN; BETA CATENIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; ENZYMATIC ASSAY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; NONHUMAN; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 9644265161     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.09.014     Document Type: Article

References (67)

1. O. Stevaux, and N.J. Dyson A revised picture of the E2F transcriptional network and RB function Curr. Opin. Cell Biol. 14 2002 684 691
2. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
3. S. Ishida, E. Huang, H. Zuzan, R. Spang, G. Leone, W. West, and J.R. Nevins Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis Mol. Cell. Biol. 21 2001 4684 4699
4. Y. Ma, R. Croxton, R.L. Moorer, and W.D. Cress Identification of novel E2F1-regulated genes by microarray Arch. Biochem. Biophys. 399 2002 212 224
5. H. Muller, A.P. Bracken, R. Vernell, M.C. Moroni, F. Christians, E. Grassilli, E. Prosperini, E. Vigo, J.D. Oliner, and K. Helin E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis Genes Dev. 15 2001 267 285
6. Z. Nahle, J. Polakoff, R.V. Davuluri, M.E. McCurrach, M.D. Jacobson, M. Narita, M.Q. Zhang, Y. Lazebnik, D. Bar-Sagi, and S.W. Lowe Direct coupling of the cell cycle and cell death machinery by E2F Nat. Cell Biol. 4 2002 859 864
7. J. Stanelle, T. Stiewe, C.C. Theseling, M. Peter, and B.M. Putzer Gene expression changes in response to E2F1 activation Nucleic Acids Res. 30 2002 1859 1867
8. A.S. Weinmann, S.M. Bartley, T. Zhang, M.Q. Zhang, and P.J. Farnham Use of chromatin immunoprecipitation to clone novel E2F target promoters Mol. Cell. Biol. 21 2001 6820 6832
9. J. Wells, C.R. Graveel, S.M. Bartley, S.J. Madore, and P.J. Farnham The identification of E2F1-specific target genes Proc. Natl. Acad. Sci. U. S. A. 99 2002 3890 3985
10. J. DeGregori, T. Kowalik, and J.R. Nevins Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes Mol. Cell. Biol. 15 1995 4215 4224 (Erratum in: Mol. Cell. Biol. 15 (1995) 5846-5847)
11. C. Stevens, and N.B. La Thangue E2F and cell cycle control: a double-edged sword Arch. Biochem. Biophys. 412 2003 157 169
12. D.G. Johnson, J.K. Schwarz, W.D. Cress, and J.R. Nevins Expression of transcription factor E2F1 induces quiescent cells to enter S phase Nature 365 1993 349 532
13. J. Lukas, B.O. Petersen, K. Holm, J. Bartek, and K. Helin Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression Mol. Cell. Biol. 16 1996 1047 1057
14. D. Ginsberg E2F1 pathways to apoptosis FEBS Lett. 529 2002 122 125
15. J. DeGregori, G. Leone, A. Miron, L. Jakoi, and J.R. Nevins Distinct roles for E2F proteins in cell growth control and apoptosis Proc. Natl. Acad. Sci. U. S. A. 94 1997 7245 7250
16. T.F. Kowalik, J. DeGregori, J.K. Schwarz, and J.R. Nevins E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis J. Virol. 69 1995 2491 2500
17. A.M. Pierce, I.B. Gimenez-Conti, R. Schneider-Broussard, L.A. Martinez, C.J. Conti, and D.G. Johnson Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53 Proc. Natl. Acad. Sci. U. S. A. 95 1998 8858 8863
18. A.M. Pierce, R. Schneider-Broussard, I.B. Gimenez-Conti, J.L. Russell, C.J. Conti, and D.G. Johnson E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model Mol. Cell. Biol. 19 1999 6408 6414
19. E. Berkovich, Y. Lamed, and D. Ginsberg E2F and Ras synergize in transcriptionally activating p14ARF expression Cell Cycle 2 2003 127 133
20. M.C. Moroni, E.S. Hickman, E.L. Denchi, G. Caprara, E. Colli, F. Cecconi, H. Muller, and K. Helin Apaf-1 is a transcriptional target for E2F and p53 Nat. Cell Biol. 3 2001 552 558
21. I. Garcia, M. Murga, A. Vicario, S.J. Field, and A.M. Zubiaga A role for E2F1 in the induction of apoptosis during thymic negative selection Cell Growth Differ. 11 2000 91 98
22. L. Yamasaki, T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N.J. Dyson Tumor induction and tissue atrophy in mice lacking E2F-1 Cell 85 1996 537 548
23. W. Yanfeng, J.P. Saint-Jeannet, and P.S. Klein Wnt-frizzled signaling in the induction and differentiation of the neural crest BioEssays 25 2003 317 325
24. M. van de Wetering, W. de Lau, and H. Clevers WNT signaling and lymphocyte development Cell 109 2002 S13 S19
25. V.L. Church, and P. Francis-West Wnt signalling during limb development Int. J. Dev. Biol. 46 2002 927 936
26. L. Alonso, and E. Fuchs Stem cells in the skin: waste not, Wnt not Genes Dev. 17 2003 1189 1200
27. M. Brittan, and N.A. Wright Gastrointestinal stem cells J. Pathol. 197 2002 492 509
28. R.H. Giles, and H. Clevers Caught up in a Wnt storm: Wnt signaling in cancer Biochim. Biophys. Acta 1653 2003 1 24
29. H. Brantjes, N. Barker, and H. Clevers TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling Biol. Chem. 383 2002 255 261
30. E. Vigo, H. Muller, E. Prosperini, G. Hateboer, P. Cartwright, M.C. Moroni, and K. Helin CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase Mol. Cell. Biol. 19 1999 6379 6395
31. J.Y. Leung, F.T. Kolligs, R. Wu, Y. Zhai, R. Kuick, S. Hanash, K.R. Cho, and E.R. Fearon Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling J. Biol. Chem. 277 2002 21657 21665
32. A. Sala, I. Casella, T. Bellon, B. Calabretta, R.J. Watson, and C. Peschle B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells J. Biol. Chem. 271 1996 9363 9367
33. M. Hubank, and D.G. Schatz Identifying differences in mRNA expression by representational difference analysis of cDNA Nucleic Acids Res. 22 1994 5640 5648
34. M. Hubank, and D.G. Schatz cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes Methods Enzymol. 303 1999 325 349
35. T.D. Littlewood, D.C. Hancock, P.S. Danielian, M.G. Parker, and G.I. Evan A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins Nucleic Acids Res. 23 1995 1686 1690
36. W.D. Cress, D.G. Johnson, and J.R. Nevins A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4 Mol. Cell. Biol. 13 1993 6314 6325
37. K. Ohtani, J. DeGregori, and J.R. Nevins Regulation of the cyclin E gene by transcription factor E2F1 Proc. Natl. Acad. Sci. U. S. A. 92 1995 12146 12150
38. X. Dong, R.S. Seelan, C. Qian, M. Mai, and W. Liu Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene Cytogenet. Cell Genet. 93 2001 26 28
39. T. Valenta, J. Lukas, and V. Korinek HMG box transcription factor TCF-4's interaction with CtBP1 controls expression of the Wnt target axin2/conductin in human embryonic kidney cells Nucleic Acids Res. 31 2003 2369 2380
40. E.H. Jho, T. Zhang, C. Domon, C.K. Joo, J.N. Freund, and F. Costantini Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway Mol. Cell. Biol. 22 2002 1172 1183
41. B. Lustig, B. Jerchow, M. Sachs, S. Weiler, T. Pietsch, U. Karsten, M. van de Wetering, H. Clevers, P.M. Schlag, W. Birchmeier, and J. Behrens Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors Mol. Cell. Biol. 22 2002 1184 1193
42. M.C. Blake, and J.C. Azizkhan Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo Mol. Cell. Biol. 9 1989 4994 5002
43. E.W. Lam, and R.J. Watson An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription EMBO J. 12 1993 2705 2713
44. M. Yamada, N. Sato, C. Taniyama, K. Ohtani, K. Arai, and H. Masai A 63-base pair DNA segment containing an Sp1 site but not a canonical E2F site can confer growth-dependent and E2F-mediated transcriptional stimulation of the human ASK gene encoding the regulatory subunit for human Cdc7-related kinase J. Biol. Chem. 277 2002 27668 27681
45. E. Neuman, E.K. Flemington, W.R. Sellers, and W.G. Kaelin Jr. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter Mol. Cell. Biol. 14 1994 6607 6615
46. Y. Takahashi, J.B. Rayman, and B.D. Dynlacht Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression Genes Dev. 14 2000 804 816
47. A. Kikuchi Modulation of Wnt signaling by Axin and Axi Cytokine Growth Factor Rev. 10 1999 255 265
48. W. Liu, X. Dong, M. Mai, R.S. Seelan, K. Taniguchi, K.K. Krishnadath, K.C. Halling, J.M. Cunningham, L.A. Boardman, C. Qian, E. Christensen, S.S. Schmidt, P.C. Roche, D.I. Smith, and S.N. Thibodeau Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling Nat. Genet. 26 2000 146 147 (Erratum in: Nat. Genet. 26 (2000) 501)
49. L. Zeng, F. Fagotto, T. Zhang, W. Hsu, T.J. Vasicek, W.L. Perry, J.J. Lee, S.M. Tilghma, B.M. Gumbiner, and F. Costantini The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation Cell 90 1997 181 192
50. V. Korinek, N. Barker, P.J. Morin, D. van Wichen, R. de Weger, K.W. Kinzler, B. Vogelstein, and E. Clevers Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma Science 275 1997 1784 1787
51. Y. Ueda, M. Hijikata, S. Takagi, R. Takada, S. Takada, T. Chiba, and K. Shimotohno Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts Int. J. Cancer 99 2002 681 688
52. N. Pediconi, A. Ianari, A. Costanzo, L. Belloni, R. Gallo, L. Cimino, A. Porcellini, I. Screpanti, C. Balsano, E. Alesse, A. Gulino, and M. Levrero Differential regulation of E2F1 apoptotic target genes in response to DNA damage Nat. Cell Biol. 5 2003 552 558
53. A. Waltermann, N.N. Kartasheva, and M. Dobbelstein Differential regulation of p63 and p73 expression Oncogene 22 2003 5686 5693
54. K. Araki, Y. Nakajima, K. Eto, and M.A. Ikeda Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter Oncogene 22 2003 7632 7641
55. R. Croxton, Y. Ma, and W.D. Cress A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4 Oncogene 21 2002 1563 1570
56. A.E. Kel, O.V. Kel-Margoulis, P.J. Farnham, S.M. Bartley, E. Wingender, and M.Q. Zhang Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors J. Mol. Biol. 309 2001 99 120
57. D.R. Schwartz, R. Wu, S.L. Kardia, A.M. Levin, C.C. Huang, K.A. Shedden, R. Kuick, D.E. Misek, S.M. Hanash, J.M. Taylor, H. Reed, N. Hendrix, Y. Zhai, E.R. Fearon, and K.R. Cho Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas Cancer Res. 63 2003 2913 2922
58. J. Willert, M. Epping, J.R. Pollack, P.O. Brown, and R. Nusse A transcriptional response to Wnt protein in human embryonic carcinoma cells BMC Dev. Biol. 2 2002 8
59. M. Classon, and E. Harlow The retinoblastoma tumour suppressor in development and cancer Nat. Rev., Cancer 2 2002 910 917
60. I.M. Oving, and H. Clevers Molecular causes of colon cancer Eur. J. Clin. Invest. 32 2002 448 457
61. N.A.C.S. Wong, and M. Pignatelli β-catenin-A linchpin in colorectal carcinogenesis? Am. J. Pathol. 160 2002 389 401
62. C.M. Phelan, A. Borg, M. Cuny, D.N. Crichton, T. Baldersson, T.I. Andersen, M.A. Caligo, R. Lidereau, A. Lindblom, S. Seitz, D. Kelsell, U. Hamann, P. Rio, S. Thorlacius, J. Papp, E. Olah, B. Ponder, Y.J. Bignon, S. Scherneck, R. Barkardottir, A.L. Borresen-Dale, J. Eyfjord, C. Theillet, A.M. Thompson, and C. Larsson Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters Cancer Res. 58 1998 1004 1012
63. S.J. Plummer, M.J. Paris, J. Myles, R. Tubbs, J. Crowe, and G. Cassey Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumours Genes Chromosomes Cancer 20 1997 354 362
64. M. Barlund, M. Tirkkonen, F. Forozan, M.M. Tanner, O. Kallioniemi, and A. Kallioniemi Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions Genes Chromosomes Cancer 20 1997 372 376
65. K. Taniguchi, L.R. Roberts, I.N. Aderca, X. Dong, C. Qian, L.M. Murphy, D.M. Nagorney, L.J. Burgart, P.C. Roche, D.I. Smith, J.A. Ross, and W. Liu Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas Oncogene 21 2002 4863 4871
66. D. Yan, M. Wiesmann, M. Rohan, V. Chan, A.B. Jefferson, L. Guo, D. Sakamoto, R.H. Caothien, J.H. Fuller, C. Reinhard, P.D. Garcia, F.M. Randazzo, J. Escobedo, W.J. Fantl, and L.T. Williams Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors Proc. Natl. Acad. Sci. U. S. A. 98 2001 14973 14978
67. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev., Cancer 3 2003 401 410